Statement from Innovative Medicines Canada on the Release of the 2024 Federal Fall Economic Statement
Ottawa, December 16, 2024 – Following the release of the Fall Economic Statement, Innovative Medicines Canada (IMC) is calling on […]
Newsroom
Put your finger on the pulse of the healthcare industry.
For media inquiries, please contact us at media@imc-mnc.ca or 613-462-5367.
PRESS RELEASES
Innovative Medicines Canada Applauds Premiers’ Agreement at 2024 Council of the Federation Meeting to Accelerate Access to Life-Saving Medications
Toronto, December 16, 2024 – Innovative Medicines Canada (IMC) welcomes the collective agreement amongst Canada’s Premiers to take meaningful action […]
Bristol-Myers Squibb Canada Wins The 2024 Prix Galien Innovative Product Award
CAMZYOS™ RECOGNIZED FOR THE TREATMENT OF obstructive hypertrophic cardiomyopathy Ottawa, November 19, 2024 – Prix Galien Canada is pleased to […]
IN THE NEWS
COMMENTARY: Canadians making desperate choices with limited clinical trials access
This article originally appeared in Saltwire newspapers across Atlantic Canada on July 11, 2024. Dr. P.J. Devereaux, co-chair of Accelerating Clinical Trials […]
Leading the way: Empowering women leaders in Canada’s pharma sector
This article originally appeared in the The Globe and Mail on March 4, 2024. Strong gender representation in workplace leadership helps businesses […]
A year later, none of the $1.5B for rare disease has flowed to patients
Further delays risk undermining the health and well-being of the very patients the National Strategy for Drugs for Rare Diseases was intended to assist.
Patient Stories
Contact
Get in touch Please complete the form below, and a representative will be in touch as soon as possible. Departments […]
Sponsorship Applications
At Innovative Medicines Canada, we offer sponsorship opportunities to facilitate research, generate awareness, create educational programs, and improve access to innovative medicines.
JOIN MEDIA LIST
Be the first to get our news
Sign up to our newsletter to get our latest news and updates.
